TScan Therapeutics Company
TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.
Technology:
Cell-based gene therapy
Industry:
PharmTech, Public
Headquarters:
Waltham, Massachusetts, United States
Founded Date:
2018-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
11
Total Funding:
197500000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-09-12
Last Funding Type:
Debt Financing
Register and Claim Ownership